Prescription medications are not the only cause for concern
In contrast, T1D is a much rarer form of the disease and only affects less than 5-10% of individuals [30]
Topical peptides are useful for certain applications (GHK-Cu copper peptide has reasonable evidence for topical activity), but for the major therapeutic peptides growth hormone secretagogues, BPC-157, Epithalon systemic delivery is required to produce the effects seen in the research literature
GLP-1 medications may be appropriate for adults who: Have a BMI of 30 or higher Have a BMI of 27 or higher with weight-related medical conditions Have struggled to lose weight through diet and exercise alone A medical consultation is required to determine if treatment is appropriate
Without medical oversight, patients may experience unnecessary side effects, plateaus, or suboptimal outcomes
Slowly push the air from the syringe into the vialthis is important for easier solution withdrawal
